Matt Niloff
About Matt Niloff
Matt Niloff Biography
Matt Niloff serves as the Chief Commercial Officer, bringing extensive experience in driving industry adoption of disruptive technologies. His career began at the MIT Center for Genome Research where he contributed to the Human Genome Project. Over the years, he has held significant roles at various organizations including Millipore, Stedim, ATMI, Sartorius, GE (now Cytiva), and Pall Corporation.
Matt Niloff's Role at Pall Corporation
At Pall Corporation, Matt Niloff was a critical leader in the Integrated Solutions program. His team was responsible for providing end-to-end manufacturing solutions and platforms. These efforts were directed towards enhancing efficiency in the scale-up and manufacturing processes of gene therapy, protein therapeutics, and vaccines.
Matt Niloff's Education Background
Matt Niloff holds both Bachelor and Master of Science degrees in Biology from McGill University in Montreal, Canada. His academic background equipped him with a solid foundation in biological sciences, which he leveraged throughout his career in the biotechnology and life sciences sectors.
Matt Niloff's Experience in Disruptive Technologies
Throughout his professional journey, Matt Niloff has been focused on fostering the industry adoption of disruptive technologies. His roles at companies like Millipore, Stedim, ATMI, Sartorius, GE (now Cytiva), and Pall Corporation highlight his commitment to innovation in the biotechnology and life sciences fields.